Dr. Thomas Adam, Bayer AG - Qepler Summits And Conferences

Dr. Thomas Adam

Head of GQA Chemical APIs
Bayer AG
Wuppertal, Germany
We exist to help people thrive - Advancing health and nutrition is what we do best and care about most.

Thomas Adam studied Chemistry at the University in Saarbruecken and Mainz, Germany.

After post-doc at Novartis, Switzerland, he joined Bayer AG. He worked in different Q-functions.

Since 2011 he is Head of GQAChemical APIs within Chemical Development Department at Bayer AG and responsible for the release of APIs for clinical trials, Qualification,Validation and Supplier Qualification.

Related Sessions:

2nd Annual Highly Potent APIs
Summit 2020

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 19 Feb 2020
  • Prague, CZ
  • Pharma
Day 1: Wednesday, 19 February 2020
CASE STUDY: HPAPI Handling from Lab Bench to Pilot Plant
  • Internal procedure GMP-guide in handling high potent compounds
  • Internal procedures to minimise the risk of handling HPAPIs to workers
  • Deciding the correct control based on a correctly identified hazard
View Details